Latest News
Would you recommend percutaneous coronary intervention (PCI) to a 60 year old man with single vessel disease and silent RCA ischemia and normal LVEF by perfusion scan?
Aggressive medical therapy only.
Aggressive medical therapy with follow-up perfusion scans.
PCI with bare metal stents (BMS) in addition to medical therapy.
PCI with drug eluting stents (DES) in addition to medical therapy.
Need additional trial data in this patient population.
[View results]
SIS Conference 2007

SIS 2007 Supporters

SIS is grateful to all past supporters and looks forward to continued collaboration in making SIS the premier educational course in cardiac, vascular, and neurovascular therapeutics on the West Coast.

 

   Cordis, a Johnson & Johnson Company
   Boston Scientific Corporation

Abbott Vascular Devices

Medtronic, Inc.

Siemens Medical Solutions USA, Inc.

AGA Medical Corporation

Bristol-Myers Squibb Company

Edwards Lifesciences
Eli Lilly & Company

NMT Medical
Pfizer, Inc.

Schering Plough
Siemens Medical Solutions USA, Inc.
TeraRecon, Inc.

Terumo Cardiovascular Systems
The Medicines Company

W.L. Gore & Associates, Inc.

AngioScore, Inc.

AstraZeneca

Boehringer-Ingelheim
Cardiva Medical

Concentric Medical
COOK Medical

ev3, Inc.
FlowCardia, Inc.
FoxHollow Technologies
GE Healthcare

Genentech, Inc.

InnerCool

Marine Polymer Technologies
Medicure Pharma

Pathway Medical Technologies, Inc.

RADI Medical Systems, Inc.

Society for Cardiovascular Angiography and Interventions

Spectranetics Corporation

Spencer Technologies
St. Jude Medical – Angio-seal

The Next Phase, Inc.
Vascular Solutions, Inc.

Vital Images, Inc.

Volcano Corporation

If you are interested in supporting SIS 2008, please contact us at info@sis.org.